Ostrum Asset Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Ostrum Asset Management's ELV Position: Q3 2026 in Review
Ostrum Asset Management increased its Elevance Health (ELV) stake by 17% in Q3 2026, buying an estimated $499K and bringing the position to 8,735 shares worth $3.4M. The position accounts for 0.16% of the portfolio, ranked #90.
Ostrum Asset Management first reported a position in ELV in Q1 2023 and has held it in 15 quarters since. The position peaked at $6.47M in Q1 2024. 1,385 funds tracked by Wall St. Rank hold ELV as of Q3 2026.
- Ostrum Asset Management held 8,735 shares of Elevance Health worth $3.4M as of Q3 2026.
- Ostrum Asset Management bought 1,250 Elevance Health shares in Q3 2026, an estimated $499K.
- Elevance Health made up 0.16% of Ostrum Asset Management's portfolio in Q3 2026, its #90 holding.
- Ostrum Asset Management first reported a position in Elevance Health in Q1 2023 and has held it in 15 quarters since.
- Ostrum Asset Management's Elevance Health position peaked at $6.47M in Q1 2024.
- 1,385 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.
Based on Ostrum Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.